-
Je něco špatně v tomto záznamu ?
Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review
L. Bacakova, J. Zarubova, M. Travnickova, J. Musilkova, J. Pajorova, P. Slepicka, NS. Kasalkova, V. Svorcik, Z. Kolska, H. Motarjemi, M. Molitor,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- buněčná diferenciace MeSH
- kmenové buňky * cytologie fyziologie MeSH
- lidé MeSH
- myši MeSH
- regenerativní lékařství * MeSH
- tkáňové inženýrství * MeSH
- transplantace kmenových buněk * MeSH
- tuková tkáň cytologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Stem cells can be defined as units of biological organization that are responsible for the development and the regeneration of organ and tissue systems. They are able to renew their populations and to differentiate into multiple cell lineages. Therefore, these cells have great potential in advanced tissue engineering and cell therapies. When seeded on synthetic or nature-derived scaffolds in vitro, stem cells can be differentiated towards the desired phenotype by an appropriate composition, by an appropriate architecture, and by appropriate physicochemical and mechanical properties of the scaffolds, particularly if the scaffold properties are combined with a suitable composition of cell culture media, and with suitable mechanical, electrical or magnetic stimulation. For cell therapy, stem cells can be injected directly into damaged tissues and organs in vivo. Since the regenerative effect of stem cells is based mainly on the autocrine production of growth factors, immunomodulators and other bioactive molecules stored in extracellular vesicles, these structures can be isolated and used instead of cells for a novel therapeutic approach called "stem cell-based cell-free therapy". There are four main sources of stem cells, i.e. embryonic tissues, fetal tissues, adult tissues and differentiated somatic cells after they have been genetically reprogrammed, which are referred to as induced pluripotent stem cells (iPSCs). Although adult stem cells have lower potency than the other three stem cell types, i.e. they are capable of differentiating into only a limited quantity of specific cell types, these cells are able to overcome the ethical and legal issues accompanying the application of embryonic and fetal stem cells and the mutational effects associated with iPSCs. Moreover, adult stem cells can be used in autogenous form. These cells are present in practically all tissues in the organism. However, adipose tissue seems to be the most advantageous tissue from which to isolate them, because of its abundancy, its subcutaneous location, and the need for less invasive techniques. Adipose tissue-derived stem cells (ASCs) are therefore considered highly promising in present-day regenerative medicine.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012767
- 003
- CZ-PrNML
- 005
- 20190405112939.0
- 007
- ta
- 008
- 190405s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biotechadv.2018.03.011 $2 doi
- 035 __
- $a (PubMed)29563048
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Bacakova, Lucie $u Department of Biomaterials and Tissue Engineering, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, 4-Krc, Czech Republic. Electronic address: Lucie.Bacakova@fgu.cas.cz.
- 245 10
- $a Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review / $c L. Bacakova, J. Zarubova, M. Travnickova, J. Musilkova, J. Pajorova, P. Slepicka, NS. Kasalkova, V. Svorcik, Z. Kolska, H. Motarjemi, M. Molitor,
- 520 9_
- $a Stem cells can be defined as units of biological organization that are responsible for the development and the regeneration of organ and tissue systems. They are able to renew their populations and to differentiate into multiple cell lineages. Therefore, these cells have great potential in advanced tissue engineering and cell therapies. When seeded on synthetic or nature-derived scaffolds in vitro, stem cells can be differentiated towards the desired phenotype by an appropriate composition, by an appropriate architecture, and by appropriate physicochemical and mechanical properties of the scaffolds, particularly if the scaffold properties are combined with a suitable composition of cell culture media, and with suitable mechanical, electrical or magnetic stimulation. For cell therapy, stem cells can be injected directly into damaged tissues and organs in vivo. Since the regenerative effect of stem cells is based mainly on the autocrine production of growth factors, immunomodulators and other bioactive molecules stored in extracellular vesicles, these structures can be isolated and used instead of cells for a novel therapeutic approach called "stem cell-based cell-free therapy". There are four main sources of stem cells, i.e. embryonic tissues, fetal tissues, adult tissues and differentiated somatic cells after they have been genetically reprogrammed, which are referred to as induced pluripotent stem cells (iPSCs). Although adult stem cells have lower potency than the other three stem cell types, i.e. they are capable of differentiating into only a limited quantity of specific cell types, these cells are able to overcome the ethical and legal issues accompanying the application of embryonic and fetal stem cells and the mutational effects associated with iPSCs. Moreover, adult stem cells can be used in autogenous form. These cells are present in practically all tissues in the organism. However, adipose tissue seems to be the most advantageous tissue from which to isolate them, because of its abundancy, its subcutaneous location, and the need for less invasive techniques. Adipose tissue-derived stem cells (ASCs) are therefore considered highly promising in present-day regenerative medicine.
- 650 _2
- $a tuková tkáň $x cytologie $7 D000273
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myši $7 D051379
- 650 12
- $a regenerativní lékařství $7 D044968
- 650 12
- $a transplantace kmenových buněk $7 D033581
- 650 12
- $a kmenové buňky $x cytologie $x fyziologie $7 D013234
- 650 12
- $a tkáňové inženýrství $7 D023822
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Zarubova, Jana $u Department of Biomaterials and Tissue Engineering, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, 4-Krc, Czech Republic.
- 700 1_
- $a Travnickova, Martina $u Department of Biomaterials and Tissue Engineering, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, 4-Krc, Czech Republic.
- 700 1_
- $a Musilkova, Jana $u Department of Biomaterials and Tissue Engineering, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, 4-Krc, Czech Republic.
- 700 1_
- $a Pajorova, Julia $u Department of Biomaterials and Tissue Engineering, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, 4-Krc, Czech Republic.
- 700 1_
- $a Slepicka, Petr $u Department of Solid State Engineering, University of Chemistry and Technology Prague, Technicka 5, 166 28 Prague, 6-Dejvice, Czech Republic.
- 700 1_
- $a Kasalkova, Nikola Slepickova $u Department of Solid State Engineering, University of Chemistry and Technology Prague, Technicka 5, 166 28 Prague, 6-Dejvice, Czech Republic.
- 700 1_
- $a Svorcik, Vaclav $u Department of Solid State Engineering, University of Chemistry and Technology Prague, Technicka 5, 166 28 Prague, 6-Dejvice, Czech Republic.
- 700 1_
- $a Kolska, Zdenka $u Faculty of Science, J.E. Purkyne University, Ceske mladeze 8, 400 96 Usti nad Labem, Czech Republic.
- 700 1_
- $a Motarjemi, Hooman $u Clinic of Plastic Surgery, Faculty Hospital Na Bulovce, Budinova 67/2, 180 81 Prague, 8-Liben, Czech Republic.
- 700 1_
- $a Molitor, Martin $u Clinic of Plastic Surgery, Faculty Hospital Na Bulovce, Budinova 67/2, 180 81 Prague, 8-Liben, Czech Republic.
- 773 0_
- $w MED00000793 $t Biotechnology advances $x 1873-1899 $g Roč. 36, č. 4 (2018), s. 1111-1126
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29563048 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190405112948 $b ABA008
- 999 __
- $a ok $b bmc $g 1392077 $s 1051072
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 36 $c 4 $d 1111-1126 $e 20180318 $i 1873-1899 $m Biotechnology advances $n Biotechnol Adv $x MED00000793
- LZP __
- $a Pubmed-20190405